[1]
M. D. Huynh, T. V. Le, L. T. T. Duong, M. C. Pham, T. N. Pham, and T. H. T. Thach, “EVALUATION OF TREATMENT OUTCOMES OF STAGE IIIB–IV NON- SMALL CELL LUNG CANCER WITH EGFR MUTATIONS USING FIRST-GENERATION TYROSINE KINASE INHIBITORS AT CAN THO CITY IN 2020 - 2023”, CTJUMP, no. 94, pp. 151–157, Jan. 2026.